Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience

- Henry, David Alexander, Kerridge, I. H., Hill, Suzanne, McNeill, P. M., Doran, Evan, Newby, David A., Henderson, Kim M., Maguire, Jane, Stokes, Barrie J., Macdonald, G. J., Day, R. O.

Moral hazard and prescription medicine use in Australia - the patient perspective

- Doran, Evan, Robertson, Jane, Henry, David

Moral hazard and prescription medicine use in Australia: the patient perspective

- Doran, Evan, Robertson, Jane, Henry, David

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry

- Henry, David, Doran, Evan, Kerridge, Ian, Hill, Suzanne, McNeill, Paul M., Day, Richard

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme

- Searles, Andrew, Jefferys, Susannah, Doran, Evan, Henry, David A.

Australian pharmaceutical policy and the idea of innovation.

- Doran, Evan, Henry, David, Faunce, Thomas A., Searles, Andrew

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia

- Doran, Evan, Henry, David, Fauce, Thomas A., Searles, Andrew

Disease mongering is now part of the global health debate

- Moynihan, Ray, Doran, Evan, Henry, David

Australia's pharmaceutical cost sharing policy: reducing waste or affordability ?

- Doran, Evan, Robertson, Jane

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

- Parkinson, Lynne, Dolja-Gore, Xenia, Gibson, Richard, Doran, Evan, Notley, Lisa, Stewart Williams, Jenny, Kowal, Paul, Byles, Julie E.

Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability

- Doran, Evan, Robertson, Jane, Salkeld, Glenn

A prompt to the web: the media and health information seeking behaviour

- Hogue, Marie-Clare B., Doran, Evan, Henry, David A.

Drug promotion in Australia: policy contestation and the tightening of regulation

- Doran, Evan, Löfgren, Hans

The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?.

- Searles, Andrew, Doran, Evan, Faunce, Thomas A., Henry, David

Potency, hubris, and susceptibility: the disease mongering critique of pharmaceutical marketing

- Doran, Evan, Hogue, Clare

Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy

- Robertson, Jane, Doran, Evan, Henry, David A., Salkeld, Glenn

Part of the fabric and mostly right: an ethnography of ethics in clinical practice

- Doran, Evan, Fleming, Jennifer, Jordens, Christopher, Stewart, Cameron L., Letts, Julie, Kerridge, Ian H.

Mixed method integrative review exploring nurses' recognition and response to unsafe practice

- Blair, Wendy, Kable, Ashley, Courtney-Pratt, Helen, Doran, Evan

Nurses’ perspectives of recognising and responding to unsafe practice by their peers: A national cross-sectional survey

- Blair, Wendy, Kable, Ashley, Palazzi, Kerrin, Courtney-Pratt, Helen, Doran, Evan, Oldmeadow, Christopher

Nurses' recognition and response to unsafe practice by their peers: A qualitative descriptive analysis

- Blair, Wendy, Courtney-Pratt, Helen, Doran, Evan, Kable, Ashley